Lee N Hanuschak,md

Endocrinology in Philadelphia, Pennsylvania

Practice Details

Address
829 Spruce St
Philadelphia, PA 19107
Geocoded location: 39.9459, -75.1560
Taxonomy
Endocrinology, Diabetes & Metabolism
NPPES Enumeration
Listed with NPPES since 2006
Registered Contact
LEE HANUSCHAK, MD
NPPES Record Updated
August 2020

About This Practice

This practice is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

This practice address has 1 individual clinician enumerated with NPPES under the same location.

Locally, this is 1 of 126 Endocrinology, Diabetes & Metabolism practices in Philadelphia carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Lee N Hanuschak,md's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 215-627-1404.

GLP-1 access in Philadelphia, Pennsylvania

Adult obesity rate
33.4%
#20 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Pennsylvania telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Pennsylvania Medicaid, obesity indication

About 33.4% of Pennsylvania adults have obesity (BMI 30+), ranking the state #20 of 50 (CDC BRFSS). Our directory currently lists 206 GLP-1-relevant clinics in Philadelphia. If a cash-pay route makes more sense, compounded semaglutide through Pennsylvania telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Pennsylvania options on the best Pennsylvania GLP-1 providers page, browse every Philadelphia listing in the Philadelphia clinic directory, or read the Pennsylvania Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Philadelphia

Other Philadelphia listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Pennsylvania addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Pennsylvania telehealth partners:

Featured Partners · Philadelphia

Featured GLP-1 providers serving Philadelphia

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Philadelphia options on the Philadelphia clinic directory, our Philadelphia GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Philadelphia obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Lee N Hanuschak,md's specialty taxonomy but not the specific medications it prescribes or its current service menu. Lee N Hanuschak,md is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 215-627-1404 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Lee N Hanuschak,md's primary specialty on file is Endocrinology.
Lee N Hanuschak,md is located at 829 Spruce St, Philadelphia, PA 19107. The phone number listed in the registry is 215-627-1404. Its full record is public in the CMS National Provider registry under NPI 1336184498.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Lee N Hanuschak,md is currently accepting new patients. Call the practice at 215-627-1404 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.